Given that HSF1 plays a role in cancer progression, metastasis, and drug resistance, and our previous finding that EGR4 is regulated by HSF1 in breast cancer cells, the aim of this study was to more fully investigate the potential oncogene EGR4 and its regulation by HSF1. Here, EGR4 is linked to breast carcinoma.